The “erasers” ALKBH5 and HOXA10 form a positive feedback loop, which eliminates the m6A modification of JAK2 mRNA and promotes cisplatin resistance in epithelial ovarian cancer by activating the JAK2/STAT3 signaling pathway. The gene discussed is JAK2; the disease is ovarian carcinoma.